Cardlytics (NASDAQ:CDLX – Get Free Report) is expected to release its Q4 2025 results after the market closes on Wednesday, March 4th. Analysts expect Cardlytics to post earnings of ($0.07) per share and revenue of $54.4560 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Wednesday, March 4, 2026 at 5:00 PM ET.
Cardlytics Stock Performance
CDLX stock opened at $0.86 on Monday. Cardlytics has a twelve month low of $0.80 and a twelve month high of $3.28. The firm has a market cap of $46.71 million, a price-to-earnings ratio of -0.41, a PEG ratio of 0.14 and a beta of 1.03. The business’s fifty day simple moving average is $1.07 and its two-hundred day simple moving average is $1.38. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 2.87.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of Cardlytics in a report on Monday, December 29th. Wall Street Zen lowered shares of Cardlytics from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Three investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Cardlytics has a consensus rating of “Reduce” and a consensus target price of $2.25.
Insider Transactions at Cardlytics
In other news, CEO Amit Gupta sold 45,159 shares of Cardlytics stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $0.93, for a total value of $41,997.87. Following the transaction, the chief executive officer directly owned 659,644 shares in the company, valued at approximately $613,468.92. This trade represents a 6.41% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Over the last quarter, insiders sold 117,875 shares of company stock worth $113,022. 4.40% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Cardlytics
A number of institutional investors have recently added to or reduced their stakes in the stock. Bank of America Corp DE grew its stake in Cardlytics by 262.7% in the third quarter. Bank of America Corp DE now owns 1,632,786 shares of the company’s stock valued at $3,968,000 after purchasing an additional 1,182,593 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Cardlytics by 3.3% in the 4th quarter. Geode Capital Management LLC now owns 654,472 shares of the company’s stock valued at $753,000 after buying an additional 20,908 shares in the last quarter. UBS Group AG grew its position in shares of Cardlytics by 112.5% in the 3rd quarter. UBS Group AG now owns 458,066 shares of the company’s stock worth $1,113,000 after buying an additional 242,536 shares during the last quarter. Invesco Ltd. grew its position in shares of Cardlytics by 38.1% in the 4th quarter. Invesco Ltd. now owns 170,122 shares of the company’s stock worth $196,000 after buying an additional 46,973 shares during the last quarter. Finally, Jane Street Group LLC raised its stake in shares of Cardlytics by 263.0% during the 2nd quarter. Jane Street Group LLC now owns 162,427 shares of the company’s stock worth $267,000 after acquiring an additional 117,687 shares in the last quarter. Institutional investors own 68.10% of the company’s stock.
About Cardlytics
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
Recommended Stories
- Five stocks we like better than Cardlytics
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- America’s 1776 happening again
- Unlocked: Elon Musk’s Next Big IPO
- Silver paying 20% dividend. Plus 68% share gains
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
